Market revenue in 2023 | USD 15.8 million |
Market revenue in 2030 | USD 21.6 million |
Growth rate | 4.5% (CAGR from 2023 to 2030) |
Largest segment | Transvenous implantable cardioverter-defibrillators |
Fastest growing segment | Subcutaneous Implantable Cardioverter Defibrillators |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Transvenous Implantable Cardioverter-Defibrillators, Subcutaneous Implantable Cardioverter Defibrillators |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, BIOTRONIK, Boston Scientific Corp, MicroPort Scientific Corp, LivaNova PLC |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to implantable cardioverter defibrillators market will help companies and investors design strategic landscapes.
Transvenous implantable cardioverter-defibrillators was the largest segment with a revenue share of 88.61% in 2023. Horizon Databook has segmented the Kuwait implantable cardioverter defibrillators market based on transvenous implantable cardioverter-defibrillators, subcutaneous implantable cardioverter defibrillators covering the revenue growth of each sub-segment from 2018 to 2030.
The primary factor driving the ICD device market in Kuwait is the increasing prevalence of heart diseases. Heart diseases, including coronary heart diseases, are a significant health concern in Kuwait, and the demand for ICDs is directly influenced by the number of people affected by these conditions.
In addition, Kuwait’s growing aging population contributes to market growth. As per the United Nations Population Fund’s World Population Dashboard data for 2021, around 3.4% of Kuwait’s population comprises individuals 65 and older.
Moreover, with the senior population being more vulnerable to CVDs, the expected expansion of this age group is likely to lead to an upsurge in demand for cardiac devices, including ICDs.
Horizon Databook provides a detailed overview of country-level data and insights on the Kuwait implantable cardioverter defibrillators market , including forecasts for subscribers. This country databook contains high-level insights into Kuwait implantable cardioverter defibrillators market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account